Bioinformatics Market

Bioinformatics Market by Product & Service (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis, Structural Analysis, Services), Applications (Genomics, Proteomics, Transcriptomics), Sectors (Medical, Animal) & Region - Global Forecast to 2027

Report Code: HIT 7543 Dec, 2022, by marketsandmarkets.com

The global bioinformatics market in terms of revenue was estimated to be worth $10.1 billion in 2022 and is poised to reach $18.7 billion by 2027, growing at a CAGR of 13.0% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of the market is driven by the increasing public and private-sector funding for bioinformatics, growth in demand for precision medicine as treatment options, rise in pharma biotech R&D expenditure, and reduced cost of genome sequencing. However, the high cost of equipment is hindering the growth of this market.

Attractive Opportunities in Bioinformatics Market

Bioinformatics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Bioinformatics Market Dynamics

Driver: Increasing public-private sector funding for bioinformatics

Many government bodies and private organizations across the globe are investing in the field of bioinformatics. These investments leads to technological advancements in bioinformatics services, which, in turn, have improved the quality of these services. For instance, in 2016, the European Molecular Biology Laboratory (EMBL), an intergovernmental organization and pioneer in bioinformatics research, received funds from the Biotechnology and Biological Sciences Research Council, British Heart Foundation, Cancer Research UK, the European Commission, European Molecular Biology Organization, the European Research Council, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program, Innovate UK, International Policy Governance Organization, the Medical Research Council, the National Institutes of Health, National Science Foundation, Parkinson’s UK, Research Councils UK, and Wellcome, for R&D in the field of bioinformatics.

Restraint: High Equipment Costs

Advancements in the NGS technologies, have led to increasing need for quick and accurate bioinformatics tools that can be easily operated. Scientists involved in experimental research are not necessarily bioinformaticians. Therefore, the availability of user-friendly tools is important for the use of bioinformatics platforms. Many bioinformatics tools require advanced computer expertise, mainly because they lack a suitable user-friendly interface.

Genomics instruments are also equipped with advanced features and functionalities come with premium, ranging between ~USD 10–20 million. As pharmaceutical and bioinfirmatics companies and research laboratories require many such systems, their capital expenditure on procuring multiple genomic instruments is very high. For small and medium-sized pharmaceutical and bioinfirmatics companies and research laboratories, it is not possible for them to make such high investments in multiple genomics instruments

Opportunity: Lucrative opportunities in emerging markets

markets like India, China, Brazil, Russia, Taiwan, and South Korea, offer high growth opportunities for the major players offering bioinformatics products and services.

The dominance of these emerging economies in terms of R&D investments from global players is expected to provide major opportunities—for the growth of genomics, transcriptomics, personalized medicine , drug discovery & clinical diagnostics , and other markets in the coming years. Also, regulatory policies in the Asia Pacific are more adaptive in nature due to fewer stringent regulations and less data requirements. The increasing competition in mature markets will further compel manufacturers to focus on emerging markets.

Challenge: Patient data confidentiality concerns

The rapid technological adoption in next-generation sequencing (NGS) technologies have generated a large volume of biological data, and with the rapid influx of data there is growing adoption of NGS. Data analysis is necessary, as a lot of information is still not researched in genome analysis. Hence, data after the process of bioinformatics analysis carries huge importance and can be reused. The current solutions offered in the market do not adequately solve the challenges of data management in bioinformatics.

North America holds the largest share in bioinformatics market

North America dominated the market, with a share of 45.1%, followed by Europe and Asia Pacific. The large share of North America in the global market can be attributed to factors such as government permissions for genetic research, key players having their headquarters in the region,  cost reduction in sequencing, awareness related to bioinformatics services, and increased number of genomic research activities (and the corresponding adoption of bioinformatics) in the region are driving the growth of the market in North America. This regional market is characterized by increased government initiatives for the reimbursement of genomic testing and favorable funding scenario for research activities involving the use of bioinformatics technologies.

Bioinformatics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The key players have a strong foothold in the market and offer a wide range of products & services. Some of the key players in this market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), Fios Genomics (UK), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.

Bioinformatics Market Report Scope:

Report Metric

Details

Market Revenue in 2022

$10.1 billion

Projected Revenue by 2027

$18.7 billion

Revenue Rate

Poised to grow at a CAGR of 13.0%

Market Driver

Increasing public-private sector funding for bioinformatics

Market Opportunity

Lucrative opportunities in emerging markets

This study categorizes the global bioinformatics market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Services

  • Knowledge Management Tools
  • Bioinformatics Platforms
  • Bioinformatics Services

By Application

  • Genomics
  • Chemoinformatics & Drug Design
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Other Applications

By Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Other Sectors

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World

Recent Developments

  • In October 2022, Illumina, Inc. and AstraZeneca formed a strategic research collaboration to expedite the discovery of therapeutic targets by combining their strengths in AI-based genome interpretation and genomic analysis tools with industry knowledge. The cooperation would assess if a framework made of both these technologies can boost target discovery yield and confidence in order to identify prospective therapeutics based on human omics insights.
  • In September 2022, Thermo Fisher Scientific joined the Pennsylvania Biotechnology Center (PABC) as a founding sponsor of both the Philadelphia-based B+Labs incubator and the PABC site in Doylestown, Pennsylvania, where emerging life science enterprises can accelerate their progress to commercialization.
  • In January 2021, BGI and the Ministry of Health of Brunei expanded their partnership to carry out extensive cooperation in public health emergency response and public health testing screening and diagnostic services, including reproductive health, personalized drug guidance, early cancer screening, and detection of unknown pathogens by using BGI’s cutting-edge sequencing technology.
  • In January 2020, Charles River Laboratories, Inc. entered into a partnership with Fios Genomics to gain access to the expertise of Fios Genomics in the field of bioinformatics, statistics, and biology.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 31)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1 INCLUSIONS AND EXCLUSIONS
           1.3.2 MARKETS COVERED
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY SOURCES
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY SOURCES
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                                FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 BIOINFORMATICS MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION (BOTTOM-UP APPROACH)
          FIGURE 5 BIOINFORMATICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
          FIGURE 6 CAGR PROJECTIONS: MARKET
          FIGURE 7 MARKET: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS 
    2.5 RISK ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 9 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2021 VS. 2027 (USD MILLION)
    FIGURE 10 BIOINFORMATICS MARKET, BY SECTOR, 2021 VS. 2027 (USD MILLION)
    FIGURE 11 BIOINFORMATICS MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION)
    FIGURE 12 GEOGRAPHICAL SNAPSHOT OF BIOINFORMATICS MARKET
 
4 PREMIUM INSIGHTS (Page No. - 47)
    4.1 BIOINFORMATICS MARKET OVERVIEW 
          FIGURE 13 INCREASING PUBLIC AND PRIVATE-SECTOR FUNDING FOR BIOINFORMATICS TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
    4.2 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE AND REGION 
          FIGURE 14 KNOWLEDGE MANAGEMENT TOOLS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.3 BIOINFORMATICS MARKET: GROWTH RATE SNAPSHOT,  BY COUNTRY 
          FIGURE 15 INDIA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 BIOINFORMATICS MARKET: REGIONAL MIX 
          FIGURE 16 NORTH AMERICA DOMINATED BIOINFORMATICS MARKET IN 2021
 
5 MARKET OVERVIEW (Page No. - 50)
    5.1 INTRODUCTION 
          FIGURE 17 BIOINFORMATICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
           5.1.1 DRIVERS
                    5.1.1.1 Increasing public and private-sector funding for bioinformatics
                                TABLE 1 PUBLIC AND PRIVATE-SECTOR FUNDING FOR BIOINFORMATICS AND RELATED FIELDS
                    5.1.1.2 Growing demand for personalized medicine
                    5.1.1.3 Increasing pharmaceutical and biotechnology R&D expenditure
                                TABLE 2 R&D INVESTMENTS BY PHARMACEUTICAL AND BIOTECHNOLOGY/ BIOINFORMATICS COMPANIES IN ASIA PACIFIC REGION
                    5.1.1.4 Decreasing cost of genome sequencing
           5.1.2 RESTRAINTS
                    5.1.2.1 High cost of equipment
           5.1.3 OPPORTUNITIES
                    5.1.3.1 Lucrative opportunities in emerging markets
                    5.1.3.2 Adoption of blockchain technology and cloud computing
                    5.1.3.3 Integration of machine learning and AI in healthcare
                    5.1.3.4 Investments by leading IT bioinfirmatics companies in development of bioinformatics solutions
           5.1.4 CHALLENGES
                    5.1.4.1 Management of large data volumes
                    5.1.4.2 Lack of interoperability and multiplatform capabilities
                    5.1.4.3 Growing competition from in-house development and publicly available tools
                    5.1.4.4 Shortage of skilled bioinformatics professionals
    5.2 PORTER’S FIVE FORCES ANALYSIS 
           5.2.1 THREAT OF NEW ENTRANTS
           5.2.2 BARGAINING POWER OF SUPPLIERS
           5.2.3 BARGAINING POWER OF BUYERS
           5.2.4 THREAT OF SUBSTITUTES
           5.2.5 INTENSITY OF COMPETITIVE RIVALRY
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 18 VALUE CHAIN ANALYSIS: MARKET
           5.3.1 RESEARCH AND DEVELOPMENT (R&D)
           5.3.2 RAW MATERIALS
           5.3.3 DISTRIBUTION AND AFTER-SALES SERVICES
    5.4 REGULATORY LANDSCAPE 
           5.4.1 NORTH AMERICA
           5.4.2 EUROPE
           5.4.3 ASIA PACIFIC
           5.4.4 MIDDLE EAST & AFRICA
           5.4.5 LATIN AMERICA
    5.5 CASE STUDIES 
    5.6 ECOSYSTEM/MARKET MAP 
          FIGURE 19 BIOINFORMATICS ECOSYSTEM
    5.7 TECHNOLOGY ANALYSIS 
          TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
    5.8 INDUSTRY TRENDS 
           5.8.1 DISCOVERY OF BIOMARKERS
           5.8.2 PROTEIN INTERACTIONS AND PATHWAYS
           5.8.3 GENETIC INTERACTION DUE TO HUMAN DISEASES
    5.9 PRICING ANALYSIS 
          TABLE 4 AVERAGE SELLING PRICE OF BIOINFORMATICS SOLUTIONS, BY PRODUCT
          TABLE 5 AVERAGE SELLING PRICE OF BIOINFORMATICS SOLUTIONS, BY SERVICE
    5.10 KEY CONFERENCES AND EVENTS 
          TABLE 6 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AMONG END USERS
                     TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AMONG END USERS
           5.11.2 BUYING CRITERIA
                     FIGURE 21 KEY BUYING CRITERIA FOR END USERS
                     TABLE 8 KEY BUYING CRITERIA FOR END USERS
 
6 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE (Page No. - 69)
    6.1 INTRODUCTION 
          TABLE 9 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
    6.2 KNOWLEDGE MANAGEMENT TOOLS 
          TABLE 10 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 11 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 12 NORTH AMERICA: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 13 EUROPE: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 14 APAC: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
           6.2.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
                    6.2.1.1 Development of novel generalized knowledge management tools to drive growth
                                TABLE 15 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.2.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
                    6.2.2.1 Data security and highly reliable information storage systems to support growth
                                TABLE 16 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION,  2020–2027 (USD MILLION)
    6.3 BIOINFORMATICS PLATFORMS 
          TABLE 17 BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 18 BIOINFORMATICS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 19 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 20 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 21 APAC: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.1 DATA ANALYSIS PLATFORMS
                    6.3.1.1 Increasing need for data analysis during sequencing programs to drive growth
                                TABLE 22 DATA ANALYSIS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.2 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS
                    6.3.2.1 Growing proteomics research worldwide to drive growth
                                TABLE 23 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.3.3 OTHER BIOINFORMATICS PLATFORMS
                    TABLE 24 OTHER BIOINFORMATICS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 BIOINFORMATICS SERVICES 
          TABLE 25 BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 26 BIOINFORMATICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 27 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 28 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 29 APAC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.4.1 SEQUENCING SERVICES
                    6.4.1.1 Financial support from government and private bodies to drive growth
                                TABLE 30 SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 31 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 32 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 33 APAC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.4.2 DATA ANALYSIS SERVICES
                    6.4.2.1 Growing adoption of big data analytics in life science research to drive growth
                                TABLE 34 DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 35 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 36 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 37 APAC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.4.3 DRUG DISCOVERY SERVICES
                    6.4.3.1 Growing technological advancements in pharmacogenomics to drive growth
                                TABLE 38 DRUG DISCOVERY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 39 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 40 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 41 APAC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.4.4 DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES
                    6.4.4.1 Increasing R&D for advancement of solutions and services for differential gene expression studies to drive growth
                                TABLE 42 DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 43 NORTH AMERICA: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 44 EUROPE: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 45 APAC: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
           6.4.5 DATABASE AND MANAGEMENT SERVICES
                    6.4.5.1 Growing volume of data generated to increase need for database and management services
                                TABLE 46 DATABASE AND MANAGEMENT SERVICES MARKET, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 47 NORTH AMERICA: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 48 EUROPE: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 49 APAC: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
           6.4.6 OTHER BIOINFORMATICS SERVICES
                    TABLE 50 OTHER BIOINFORMATICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 51 NORTH AMERICA: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 52 EUROPE: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 53 APAC: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
 
7 BIOINFORMATICS MARKET, BY APPLICATION (Page No. - 91)
    7.1 INTRODUCTION 
          TABLE 54 BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    7.2 GENOMICS 
           7.2.1 DECREASING COST OF NEXT-GENERATION SEQUENCING TO BOOST GROWTH
                    TABLE 55 GENOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 CHEMOINFORMATICS & DRUG DESIGN 
           7.3.1 GROWING USE IN DRUG DESIGNING PROCESS BY PHARMACEUTICAL AND BIOINFORMATICS COMPANIES TO DRIVE GROWTH
                    TABLE 56 CHEMOINFORMATICS & DRUG DESIGN MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.4 PROTEOMICS 
           7.4.1 INCREASING APPLICATIONS IN DRUG DISCOVERY TO DRIVE GROWTH
                    TABLE 57 PROTEOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.5 TRANSCRIPTOMICS 
           7.5.1 TRANSCRIPTOMICS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
                    TABLE 58 TRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.6 METABOLOMICS 
           7.6.1 INCREASING RESEARCH FUNDING TO DRIVE GROWTH
                    TABLE 59 METABOLOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.7 OTHER APPLICATIONS 
          TABLE 60 OTHER APPLICATIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
 
8 BIOINFORMATICS MARKET, BY SECTOR (Page No. - 97)
    8.1 INTRODUCTION 
          TABLE 61 BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
    8.2 MEDICAL BIOTECHNOLOGY 
          TABLE 62 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY SECTOR,  2020–2027 (USD MILLION)
          TABLE 63 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY REGION,  2020–2027 (USD MILLION)
          TABLE 64 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 65 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 66 APAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
           8.2.1 DRUG DISCOVERY & DEVELOPMENT
                    8.2.1.1 Increasing adoption of bioinformatics services and products for drug designing to drive growth
                                TABLE 67 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION,  2020–2027 (USD MILLION)
           8.2.2 CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE
                    8.2.2.1 Focus on development of bioinformatics tools for personalized medicine to propel growth
                                TABLE 68 MARKET FOR CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE,  BY REGION, 2020–2027 (USD MILLION)
           8.2.3 REPRODUCTIVE HEALTH
                    8.2.3.1 Increasing R&D on reproductive health to bolster market growth
                                TABLE 69 MARKET FOR REPRODUCTIVE HEALTH, BY REGION,  2020–2027 (USD MILLION)
    8.3 ANIMAL BIOTECHNOLOGY 
           8.3.1 RAPID ADVANCES IN UNDERSTANDING OF FARM ANIMAL GENOMES TO AID MARKET GROWTH
                    TABLE 70 BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 71 NORTH AMERICA: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 72 EUROPE: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 73 APAC: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
    8.4 PLANT BIOTECHNOLOGY 
           8.4.1 INCREASED USE OF BIOINFORMATICS FOR TIME AND COST-EFFICIENT R&D IN AGRICULTURE TO DRIVE MARKET GROWTH
                    TABLE 74 BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 75 NORTH AMERICA: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 76 EUROPE: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 77 APAC: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
    8.5 ENVIRONMENTAL BIOTECHNOLOGY 
           8.5.1 INCREASING USE OF NGS FOR ENVIRONMENTAL BIOTECHNOLOGY APPLICATIONS TO DRIVE MARKET GROWTH
                    TABLE 78 BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 79 NORTH AMERICA: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 80 EUROPE: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 81 APAC: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY,  BY COUNTRY, 2020–2027 (USD MILLION)
    8.6 FORENSIC BIOTECHNOLOGY 
           8.6.1 INCREASING AVAILABILITY OF ADVANCED SOFTWARE FOR INVESTIGATIONAL PURPOSES TO DRIVE GROWTH
                    TABLE 82 BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 83 NORTH AMERICA: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 84 EUROPE: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 85 APAC: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
    8.7 OTHER SECTORS 
          TABLE 86 BIOINFORMATICS MARKET FOR OTHER SECTORS, BY REGION,  2020–2027 (USD MILLION)
          TABLE 87 NORTH AMERICA: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 88 EUROPE: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 89 APAC: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY,  2020–2027 (USD MILLION)
 
9 BIOINFORMATICS MARKET, BY REGION (Page No. - 114)
    9.1 INTRODUCTION 
          TABLE 90 BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 22 NORTH AMERICA: BIOINFORMATICS MARKET SNAPSHOT (2021)
          TABLE 91 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 92 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
          TABLE 93 NORTH AMERICA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 94 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 95 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 96 NORTH AMERICA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
          TABLE 97 NORTH AMERICA: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 98 NORTH AMERICA: BIOINFORMATICS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 US dominated North American market in 2021
                                TABLE 99 US: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
                                TABLE 100 US: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 101 US: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 102 US: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 103 US: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 104 US: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 105 US: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Growth in genomics field to drive market
                                TABLE 106 CANADA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
                                TABLE 107 CANADA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 108 CANADA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 109 CANADA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 110 CANADA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 111 CANADA: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 112 CANADA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.3 EUROPE 
          FIGURE 23 EUROPE: BIOINFORMATICS MARKET SNAPSHOT (2021)
          TABLE 113 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 114 EUROPE: MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
          TABLE 115 EUROPE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 116 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 117 EUROPE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 118 EUROPE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
          TABLE 119 EUROPE: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 120 EUROPE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany expected to be largest market for bioinformatics products and services in Europe
                                TABLE 121 GERMANY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
                                TABLE 122 GERMANY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 123 GERMANY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 124 GERMANY: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 125 GERMANY: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 126 GERMANY: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 127 GERMANY: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Increasing genomics research to drive market growth
                                TABLE 128 UK: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                TABLE 129 UK: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 130 UK: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 131 UK: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 132 UK: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 133 UK: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 134 UK: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Government initiatives for genomics research to drive market growth
                                TABLE 135 FRANCE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
                                TABLE 136 FRANCE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 137 FRANCE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 138 FRANCE: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 139 FRANCE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 140 FRANCE: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 141 FRANCE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increasing research in genomics to drive market growth
                                TABLE 142 ITALY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                TABLE 143 ITALY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 144 ITALY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 145 ITALY: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 146 ITALY: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 147 ITALY: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 148 ITALY: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Presence of several local players in Spanish bioinformatics market to drive growth
                                TABLE 149 SPAIN: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                TABLE 150 SPAIN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 151 SPAIN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 152 SPAIN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 153 SPAIN: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 154 SPAIN: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 155 SPAIN: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 156 ROE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                    TABLE 157 ROE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                    TABLE 158 ROE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 159 ROE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 160 ROE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                    TABLE 161 ROE: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                    TABLE 162 ROE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC 
          FIGURE 24 ASIA PACIFIC: BIOINFORMATICS MARKET SNAPSHOT (2021)
          TABLE 163 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 164 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
          TABLE 165 ASIA PACIFIC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 166 ASIA PACIFIC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 167 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 168 ASIA PACIFIC: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
          TABLE 169 ASIA PACIFIC: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 170 ASIA PACIFIC: BIOINFORMATICS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Partnerships and collaborations between various industry stakeholders driving development of bioinformatics
                                TABLE 171 CHINA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                TABLE 172 CHINA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 173 CHINA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 174 CHINA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 175 CHINA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 176 CHINA: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 177 CHINA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Growing focus of Japanese bioinformatics firms on product launches and collaborations to drive growth
                                TABLE 178 JAPAN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                TABLE 179 JAPAN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 180 JAPAN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 181 JAPAN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 182 JAPAN: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 183 JAPAN: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 184 JAPAN: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Increasing outsourcing of pharmaceutical drug discovery to drive growth
                                TABLE 185 INDIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                TABLE 186 INDIA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 187 INDIA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 188 INDIA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 189 INDIA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                                TABLE 190 INDIA: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 191 INDIA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 192 ROAPAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
                    TABLE 193 ROAPAC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                    TABLE 194 ROAPAC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 195 ROAPAC: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 196 ROAPAC: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
                    TABLE 197 ROAPAC: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
                    TABLE 198 ROAPAC: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.5 REST OF THE WORLD 
          TABLE 199 ROW: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
          TABLE 200 ROW: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 201 ROW: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 202 ROW: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 203 ROW: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION)
          TABLE 204 ROW: MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 205 ROW: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 168)
     10.1 INTRODUCTION 
     10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN 
             TABLE 206 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN BIOINFORMATICS MARKET
     10.4 MARKET RANKING ANALYSIS, 2021 
             FIGURE 26 RANK OF BIOINFORMATICS COMPANIES IN GLOBAL MARKET, 2021
     10.5 COMPETITIVE LEADERSHIP MAPPING 
             10.5.1 STARS
             10.5.2 PERVASIVE PLAYERS
             10.5.3 EMERGING LEADERS
             10.5.4 PARTICIPANTS
                       FIGURE 27 BIOINFORMATICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
     10.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2021) 
             10.6.1 PROGRESSIVE BIOINFORMATICS COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE BIOINFORMATICS COMPANIES
             10.6.4 DYNAMIC BIOINFORMATICS COMPANIES
                       FIGURE 28 BIOINFORMATICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
     10.7 COMPETITIVE BENCHMARKING 
             TABLE 207 FOOTPRINT OF BIOINFORMATICS COMPANIES
             TABLE 208 PRODUCT & SERVICE FOOTPRINT OF BIOINFORMATICS COMPANIES
             TABLE 209 REGIONAL FOOTPRINT OF BIOINFORMATICS COMPANIES
     10.8 COMPETITIVE SCENARIO 
             10.8.1 PRODUCT & SERVICE LAUNCHES
                        TABLE 210 MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2019–NOVEMBER 2022
             10.8.2 DEALS
                        TABLE 211 BIOINFORMATICS MARKET: DEALS, JANUARY 2019–NOVEMBER 2022
 
11 COMPANY PROFILES (Page No. - 182)
     11.1 KEY PLAYERS 
(Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats)*
             11.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 212 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                        FIGURE 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
             11.1.2 EUROFINS SCIENTIFIC
                        TABLE 213 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 30 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
             11.1.3 ILLUMINA, INC.
                        TABLE 214 ILLUMINA, INC.: BUSINESS OVERVIEW
                        FIGURE 31 ILLUMINA, INC.: COMPANY SNAPSHOT (2021)
             11.1.4 PERKINELMER, INC.
                        TABLE 215 PERKINELMER, INC.: BUSINESS OVERVIEW
                        FIGURE 32 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
             11.1.5 NEOGENOMICS LABORATORIES
                        TABLE 216 NEOGENOMICS LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 33 NEOGENOMICS LABORATORIES: COMPANY SNAPSHOT (2021)
             11.1.6 QIAGEN N.V.
                        TABLE 217 QIAGEN N.V.: BUSINESS OVERVIEW
                        FIGURE 34 QIAGEN N.V.: COMPANY SNAPSHOT (2021)
             11.1.7 SOURCE BIOSCIENCE
                        TABLE 218 SOURCE BIOSCIENCE: BUSINESS OVERVIEW
                        FIGURE 35 SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2021)
             11.1.8 AGILENT TECHNOLOGIES, INC.
                        TABLE 219 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
             11.1.9 DNASTAR
                        TABLE 220 DNASTAR: BUSINESS OVERVIEW
             11.1.10 PSOMAGEN, INC. (FORMERLY MACROGEN CORP.)
                        TABLE 221 PSOMAGEN, INC.: BUSINESS OVERVIEW
     11.2 OTHER PLAYERS 
             11.2.1 WATERS CORPORATION
             11.2.2 MICROSYNTH
             11.2.3 GENEWIZ (A BROOKS LIFE SCIENCES COMPANY)
             11.2.4 MEDGENOME LABS LTD.
             11.2.5 PARTEK
             11.2.6 BEIJING GENOMICS INSTITUTE (BGI)
             11.2.7 BIOMAX INFORMATICS AG
             11.2.8 SOPHIA GENETICS
             11.2.9 FIOS GENOMICS
             11.2.10 GENUITY SCIENCE (FORMERLY WUXI NEXTCODE)
             11.2.11 PETDX
             11.2.12 JADBIO
             11.2.13 BIOSYSTEMS IMMUNOLAB PLC.
             11.2.14 ASTALAKE BIOSYSTEMS
             11.2.15 NUCLEOME INFORMATICS PVT. LTD.
 
*Details on Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices made, and weaknesses and competitive threats might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 228)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved four major activities in estimating the size of the bioinformatics market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

This research study involved the use of widespread secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for this extensive, technical, market-oriented, and commercial study of the bioinformatics market. It was also used to obtain important information about the key players alongside market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the bioinformatics market. It was also used to obtain important information about key market players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.

The primary sources from the supply side include CEOs, VPs, managing directors, marketing and sales heads/directors, marketing managers, regional/area sales managers, and bioinformatics scientists. Primary sources from the demand side include vice presidents, C-level executives, product managers, department heads, research scientists, research heads, and hospital directors. Other primary respondents include industry experts such as consultants, government, and officials/regulatory authorities.

Breakdown of Primary Interviews

Bioinformatics Market Size, and Share

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioinformatics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.

Report Objectives

  • To define, describe, and forecast the bioinformatics market based on products & services, application, sector, and region
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall bioinformatics market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely,
    North America, Europe, Asia Pacific and Rest of the World.
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments such as product/service launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall bioinformatics market
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of bioinformatics market
  • Profiling of additional market players (up to 3)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 7543
Published ON
Dec, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Bioinformatics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback